Charles Silberstein
2020
In 2020, Charles Silberstein earned a total compensation of $9.3M as Chief Financial Officer at Applied Therapeutics.
Compensation breakdown
| Bonus | $108,197 |
|---|---|
| Option Awards | $6,282,494 |
| Salary | $270,000 |
| Stock Awards | $2,685,220 |
| Total | $9,345,911 |
Silberstein received $6.3M in option awards, accounting for 67% of the total pay in 2020.
Silberstein also received $108.2K in bonus, $270K in salary and $2.7M in stock awards.
Rankings
In 2020, Charles Silberstein's compensation ranked 923rd out of 13,090 executives tracked by ExecPay. In other words, Silberstein earned more than 92.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 923 out of 13,090 | 93rd |
Division Manufacturing | 324 out of 5,620 | 94th |
Major group Chemicals And Allied Products | 104 out of 2,253 | 95th |
Industry group Drugs | 91 out of 1,953 | 95th |
Industry Pharmaceutical Preparations | 71 out of 1,458 | 95th |
Source: SEC filing on April 21, 2021.
Silberstein's colleagues
We found two more compensation records of executives who worked with Charles Silberstein at Applied Therapeutics in 2020.